|1|The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening. (27160733)
van Luijt P.A.... de Koning H.J.
|2|The immune microenvironment of breast ductal carcinoma in situ. (26769139)
Thompson E.... Emens L.A.
|3|Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020). (26542585)
Nakhlis F.... King T.A.
|4|A Call for Change in the Diagnosis and Treatment of Patients with Ductal Carcinoma In Situ: An Opportunity to Minimize Overdiagnosis and Overtreatment. (26547899)
|5|Histopathological characteristics of breast ductal carcinoma in situ and association with imaging findings. (25644245)
Tang X.... Masuda S.
|6|Paget's disease of the male breast with underlying ductal carcinoma in situ. (25739183)
Leibou L.... Mordechai S.
|7|Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast. (24948027)
Gomes D.S.... Gobbi H.
|8|The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast. (24433818)
Barnes N.L.... Bundred N.J.
|9|Hypofractionated radiation therapy for breast ductal carcinoma in situ. (24113057)
Hathout L.... Yassa M.
|10|US appearance of ductal carcinoma in situ. (23322838)
Wang L.C.... Mendelson E.B.
|11|Factors influencing the quality of local management of ductal carcinoma in situ: a cohort study. (23737691)
Krotneva S.P.... Meguerditchian A.N.
|12|Near-infrared fluorescence molecular imaging of ductal carcinoma in situ with CD44v6-specific antibodies in mice: a preclinical study. (23184608)
Vermeulen J.F.... Derksen P.W.
|13|Progression from ductal carcinoma in situ to invasive breast cancer: revisited. (23890733)
Cowell C.F.... Reis-Filho J.S.
|14|Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy. (23007901)
Park H.S.... Park B.W.
|15|Molecular phenotypes of ductal carcinoma-in-situ and invasive ductal carcinoma: a comparative study. (22499299)
Gupta S.... Singh S.
|16|Multi-institutional experience of ductal carcinoma in situ in black vs white patients treated with breast-conserving surgery and whole breast radiation therapy. (22672752)
Nelson C.... Moran M.S.
|17|Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia. (22134623)
Knudsen E.S.... Witkiewicz A.K.
|18|Cell polarity, epithelial-mesenchymal transition, and cell-fate decision gene expression in ductal carcinoma in situ. (22577534)
Coradini D.... Oriana S.
|19|Breast cancer and ductal carcinoma in situ among women with prior squamous or glandular precancer in the cervix: a register-based study. (23011481)
Hansen B.T.... Hofvind S.
|20|Should axillary ultrasound be used in patients with a preoperative diagnosis of ductal carcinoma in situ? (22749764)
Ansari B.... Morton M.J.
|21|Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ. (22674478)
Arvold N.D.... Hassett M.J.
|22|Twenty-year outcomes after breast-conserving surgery and definitive radiotherapy for mammographically detected ductal carcinoma in situ. (22644510)
Wilkinson J.B.... Chen P.Y.
|23|Intraoperative assessment of surgical margins during breast conserving surgery of ductal carcinoma in situ by use of radiofrequency spectroscopy. (21885281)
Thill M.... Dittmer C.
|24|Tissue microarray-based immunohistochemical study can significantly underestimate the expression of HER2 and progesterone receptor in ductal carcinoma in situ of the breast. (20701550)
Lin Y.... Tang P.
|25|Pyoderma gangrenosum of the breast after bilateral simple mastectomies for ductal carcinoma in situ. (21944335)
Leppard W.M.... Barbour J.R.
|26|Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons. (21200025)
Dick A.W.... Griggs J.J.
|27|Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast. (20704578)
Tamaki K.... Ohuchi N.
|28|Ductal carcinoma in situ: terminology, classification, and natural history. (20956817)
|29|Proceedings of the National Institutes of Health State-of-the-Science Conference, Diagnosis and Management of Ductal Carcinoma In Situ. September 2009. (21312388) |2010|
|30|Quality-of-life issues in patients with ductal carcinoma in situ. (20956834)
|31|The use of oncoplastic reduction techniques to reconstruct partial mastectomy defects in women with ductal carcinoma in situ. (20102367)
Song H.M.... Losken A.
|32|Gene amplification in ductal carcinoma in situ of the breast. (20033484)
Burkhardt L.... Lebeau A.
|33|Coronal serial sequential sampling of breast specimen in the assessment of the extent of ductal carcinoma in situ. (19722734)
Mai K.T.... Burns B.F.
|34|Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case. (19886717)
|35|Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients. (19950406)
Collins L.C.... Habel L.A.
|36|Intracrinology of sex steroids in ductal carcinoma in situ (DCIS) of human breast: comparison to invasive ductal carcinoma (IDC) and non-neoplastic breast. (19444935)
Miki Y.... Sasano H.
|37|Ductal carcinoma in situ in BRCA mutation carriers. (17210933)
Hwang E.S.... Ziegler J.L.
|38|Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ? (15832086)
Tan P.H.... Tse G.M.
|39|Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ. (15827818)
El-Tamer M.... Mansukhani M.
|40|Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast. (15788662)
Barnes N.L.... Bundred N.J.
|41|Correlation of HER2 gene amplification with expression of the apoptosis-suppressing genes bcl-2 and bcl-x-L in ductal carcinoma in situ of the breast. (15722788)
Siziopikou K.P.... Khan S.
|42|S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast. (15217497)
Emberley E.D.... Watson P.H.
|43|Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast. (12147647)
Rice A.... Quinn C.M.
|44|Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. (11912139)
Half E.... Sinicrope F.A.
|45|Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. (12434415)
Boecker W.... Buchwalow I.B.
|46|p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast. (11333292)
Done S.J.... Andrulis I.L.
|47|Atypical cystic lobule of the breast: an early stage of low-grade ductal carcinoma in-situ. (11114859)
Oyama T.... Koerner F.
|48|Immunohistochemical detection of oestrogen receptors in ductal carcinoma in situ of the breast. (9005143)
Karayiannakis A.J.... Karamanakos P.
|49|High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. (8968105)
Man S.... Brook J.D.
|50|Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast. (8385977)
Luqmani Y.A.... Coombes R.C.